Physician

Adam Bryce Mckenzie, D.O.

According to 2025 Medicare claims, Adam Mckenzie, D.O. (NPI: 1639433428) practices pulmonary disease, with the plurality of this provider's patient population coming from Craven, NC. This provider's primary affiliated billing organization is COASTAL CAROLINA HEALTH CARE PA (NPI: 1780623207; TIN: 562054060) and primary practice location at 28562-5252. Mckenzie is affiliated with the Commonwealth Primary Care ACO LLC (ACO ID: D0224), participating under the REACH model.

Mckenzie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 902 traditional Medicare patients, billed 3,992 HCPCS/CPT codes, and received $194,033 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,591 prescription claims across 613 beneficiaries totaling $2,311,332 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,203 claims. Open Payments data shows 94 records totaling $2,014. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $20,519 to $2,311,332. For DME billing, reported payments moved sharply higher in recent years, from $1,053 to $134,393.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	241	1,577	$57,539
2019	906	23,725	$292,587
2020	895	12,510	$297,245
2021	1,053	9,026	$318,348
2022	1,025	5,793	$293,864
2023	1,015	4,743	$260,587
2024	902	3,992	$194,033

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	78	158	$20,519
2019	248	1,045	$382,636
2020	350	1,918	$934,654
2021	404	2,311	$1,098,095
2022	438	2,521	$1,294,264
2023	494	2,934	$1,687,784
2024	613	3,591	$2,311,332

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$54
2019	136	684	$30,051
2020	341	1,700	$96,585
2021	437	2,096	$131,345
2022	456	2,227	$135,305
2023	523	2,312	$140,078
2024	473	2,203	$351,310

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	557	907	$83
94729	Test to examine how well the lungs exchange gases	449	507	$35
94726	Test to determine lung volumes using sensors	213	214	$33
94010	Test to measure expiratory airflow and volume	466	533	$16
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	491	672	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	695	26,730	$560,579
Ofev	Nintedanib Esylate	20	600	$262,814
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	342	11,910	$174,696
Arikayce	Amikacin Liposomal/Neb.Accessr	11	308	$169,751
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	258	10,288	$159,311

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7686	Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg	N	N/R	11	$179,824
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	68	473	$56,003
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	39	$29,682
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	26	$27,193
A7030	Full face mask used with positive airway pressure device, each	N	24	45	$5,715

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	94	$2,014	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Bryce Mckenzie, D.O.?

Tedicare shows public-source Medicare data for Adam Bryce Mckenzie, D.O. (NPI 1639433428), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Bryce Mckenzie, D.O. have ACO affiliation data?

Adam Bryce Mckenzie, D.O. is shown with ACO affiliation data for Commonwealth Primary Care ACO LLC (REACH, ACO ID D0224).

What billing organization is linked to Adam Bryce Mckenzie, D.O.?

Adam Bryce Mckenzie, D.O. is linked to COASTAL CAROLINA HEALTH CARE PA (billing NPI 1780623207) in the available physician profile data.

Does Adam Bryce Mckenzie, D.O. have Open Payments data?

Adam Bryce Mckenzie, D.O. has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.